Zim Laboratories Ltd
BSE:541400
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zim Laboratories Ltd
BSE:541400
|
IN |
|
Amal Ltd
BSE:506597
|
IN |
|
I
|
IDream Film Infrastructure Company Ltd
BSE:504375
|
IN |
|
T
|
TFE Co Ltd
KOSDAQ:425420
|
KR |
|
Quidel Corp
NASDAQ:QDEL
|
US |
|
Metso Outotec Corp
OTC:OUKPY
|
FI |
|
Heidelberger Druckmaschinen AG
XETRA:HDD
|
DE |
|
P
|
Psyence Group Inc
CNSX:PSYG
|
CA |
|
L
|
Lingo Media Corp
XTSX:LM
|
CA |
|
C
|
CuroHoldings Co Ltd
KOSDAQ:051780
|
KR |
|
Kweichow Moutai Co Ltd
SSE:600519
|
CN |
|
Zip Co Ltd
ASX:Z1P
|
AU |
|
Proya Cosmetics Co Ltd
SSE:603605
|
CN |
|
I
|
Inbest Prime II Inmuebles SOCIMI SA
MAD:YINB2
|
ES |
|
KDDL Ltd
NSE:KDDL
|
IN |
|
Basanite Inc
OTC:BASA
|
US |
|
R
|
Rex Trueform Group Ltd
JSE:RTO
|
ZA |
|
Galway Metals Inc
XTSX:GWM
|
CA |
|
Q
|
Quang Nam Transportation Construction JSC
VN:QTC
|
VN |
Bankruptcy Probability
Zim Laboratories Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Zim Laboratories Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Zim Laboratories Ltd
NSE:ZIMLAB
|
3.2B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Zim Laboratories Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Zim Laboratories Ltd has total debt of 467.2m INR. This includes both short-term (0 INR) and long-term (467.2m INR) debt.
You can find a full breakdown on its Balance Sheet.